Abstract
Lung transplantation remains as a vital treatment for patients with end-stage lung disease. The successful transplant of an allograft begins with the allocation of a suitable graft to an appropriate recipient. Donor lungs are considered a scarce resource which can provide the recipient years of an improved quality of life. Donation after brain death has traditionally been the source of lung grafts and remains the source of >90% of lung transplants. Living donor lobar lung transplantation is the newest source of donor lung allograft. The utility of lobar transplantation, as an alternative to whole lung transplant, was first described in infants. ABO compatibility plays a role in all solid-organ transplants. The preretrieval evaluation of the donor’s viral serologies is essential. The presence of human immunodeficiency virus, hepatitis B, hepatitis C, or cytomegavirus can influence treatment options.
| Original language | English |
|---|---|
| Title of host publication | Textbook of Transplantation and Mechanical Support for End-Stage Heart and Lung Disease |
| Publisher | wiley |
| Pages | 1110-1118 |
| Number of pages | 9 |
| ISBN (Electronic) | 9781119633884 |
| ISBN (Print) | 9781119633846 |
| DOIs | |
| State | Published - 1 Jan 2023 |
Keywords
- ABO compatibility
- donation after brain death
- end-stage lung disease
- hepatitis B
- hepatitis C
- human immunodeficiency virus
- living donor lobar lung transplantation
- lung transplantation
